NOTCH1 and EGFR have been demonstrated to have antagonistic effects in skin cancer, where suppression of EGFR results in enhanced differentiation of squamous cell carcinoma cells and increased resistance to apoptosis. Here, EGFR is linked to squamous cell carcinoma.